Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Amgen And Syapse Enter Precision Medicine Collaboration In Oncology

Friday, May 03, 2019

Amgen a world leader in biotechnology and Syapse a company powering precision medicine insights through its global provider network today announced a precision medicine collaboration in oncology

Tmunity and UC San Francisco Announce Exclusive License and Research Collaboration to Advance TCR T Cell Therapies for Pediatric Cancers

Thursday, May 02, 2019

Tmunity Therapeutics Inc a private clinicalstage biotherapeutics company focused on saving and improving lives by delivering the full potential of nextgeneration T cell immunotherapy today announced it has entered into an exclusive licensing and rese...

CStone and Numab announce exclusive regional licensing agreement for ND021

Thursday, May 02, 2019

CStone Pharmaceuticals and Numab Therapeutics AG Numab today announce that they have entered into an exclusive regional licensing agreement for the development and commercialization of ND a potential bestinclass monovalent trispecific antibodybased...

Sandoz enters agreement for proposed trastuzumab biosimilar, currently in Phase III development, to treat selected HER2-positive cancer tumors

Wednesday, May 01, 2019

Sandoz a Novartis division and a global leader in biosimilars today announced that it has entered into an agreement to commercialize a proposed trastuzumab biosimilar This medicine is currently in Phase III clinical development for treatment of human...

Vivera Pharmaceuticals Licenses TABMELT®, a Sublingual Pharmaceutical Drug-Delivery System for Cannabidiol (CBD)

Wednesday, May 01, 2019

Vivera Pharmaceuticals Inc a pharmaceutical company focused on nonaddictive pain management today announces the debut of TABMELT a sublingual drug delivery system that Vivera has exclusively licensed for the specific use for pharmaceutical cannabinoi...

EirGenix, Inc. Enters Into Global License Agreement for the Commercialization of its Biosimilar Drug EG12014

Tuesday, April 30, 2019

EirGenix Inc announced today that it has entered into a license agreement with global generic and biosimilar drug manufacturer Sandoz AG granting an exclusive license to Sandoz for right of commercialization of EirGenix s breast cancer biosimilar dru...

Canopy Biosciences Acquires Zellkraftwerk GmbH

Tuesday, April 30, 2019

Canopy BiosciencesTM LLC a leading provider of gene editing and gene expression products and services announced today that it has acquired Zellkraftwerk GmbH a leader in multiplex cytometryLeveraging its innovative ChipCytometry platform Zellkraftwer...

Cardinal Health Specialty Solutions Strengthens Cell and Gene Therapy Offering with PANTHERx Specialty Pharmacy Collaboration

Monday, April 29, 2019

To meet the growing needs of the market Cardinal Health Specialty Solutions has strengthened its cell and gene therapy capability with a coordinated suite of specialty distribution thirdparty logistics PL services and specialty pharmacy dispensing se...

Salix Enters Into Exclusive License Agreement With Mitsubishi Tanabe Pharma

Friday, April 26, 2019

Salix Pharmaceuticals Salix one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases and a wholly owned subsidiary of Bausch Health Companies Inc announced today that it...

Mateon and Oncotelic Complete Their Merger and Create a New Immuno-Oncology Company with a Late-Stage Clinical Asset Against Cancer and a Promising Product Pipeline

Friday, April 26, 2019

Mateon Therapeutics Inc and Oncotelic Inc announced today that they have completed their previously announced merger The combined company has a focused pipeline of TGF RNA Therapeutics for late stage cancers including gliomas pancreatic cancer and me...